Healthcare -
Biotechnology - NASDAQ - US
$ 5.28
-2.94 %
$ 201 M
Market Cap
-3.3
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
114.57%
EBIT
Estimate
35.79%
Net Income
Estimate
12.51%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Orchestra BioMed Holdings, Inc.
OBIO has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart OBIO
EBIT FORECAST
EBIT Forecast Chart OBIO
NET INCOME FORECAST
Net Income Chart OBIO